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Abstract
Although viruses have been implicated in central nervous system (CNS) diseases of unknown etiology, including multiple
sclerosis and amyotrophic lateral sclerosis, the reproducible identification of viral triggers in such diseases has been largely
unsuccessful. Here, we explore the hypothesis that viruses need not replicate in the tissue in which they cause disease;
specifically, that a peripheral infection might trigger CNS pathology. To test this idea, we utilized a transgenic mouse model
in which we found that immune cells responding to a peripheral infection are recruited to the CNS, where they trigger
neurological damage. In this model, mice are infected with both CNS-restricted measles virus (MV) and peripherally
restricted lymphocytic choriomeningitis virus (LCMV). While infection with either virus alone resulted in no illness, infection
with both viruses caused disease in all mice, with ,50% dying following seizures. Co-infection resulted in a 12-fold increase
in the number of CD8+ T cells in the brain as compared to MV infection alone. Tetramer analysis revealed that a substantial
proportion (.35%) of these infiltrating CD8+ lymphocytes were LCMV-specific, despite no detectable LCMV in CNS tissues.
Mechanistically, CNS disease was due to edema, induced in a CD8-dependent but perforin-independent manner, and brain
herniation, similar to that observed in mice challenged intracerebrally with LCMV. These results indicate that T cell
trafficking can be influenced by other ongoing immune challenges, and that CD8+ T cell recruitment to the brain can trigger
CNS disease in the apparent absence of cognate antigen. By extrapolation, human CNS diseases of unknown etiology need
not be associated with infection with any particular agent; rather, a condition that compromises and activates the blood-
brain barrier and adjacent brain parenchyma can render the CNS susceptible to pathogen-independent immune attack.
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Introduction
Despite the exquisitely specific activation of the adaptive
immune response following antigenic encounter, recruitment of
immune cells to the affected site is governed by relatively
nonspecific factors, including chemokine gradients and adhesion
molecule induction on barrier endothelia [1–3]. Indeed, some
studies have shown that activated immune cells can be recruited to
a tissue where no cognate antigen exists. For example, using a
mouse model of influenza infection, it was shown that primed
transgenic CD4+ T cells that were specific for ovalbumin (with no
cross-reactivity to flu) migrated efficiently to the infected lung.
Despite such recruitment, these cells did not proliferate [4],
showing that T cell recruitment and proliferation can be
uncoupled.
The complexity of concurrent immune challenges that humans
are likely to encounter is staggering, including myriad combina-
tions of pathogens, allergens, and vaccines. In fact, many human
and animal diseases are caused by polymicrobial exposures,
including human pneumonia, otitis media, peritonitis and
periodontitis. Other diseases, such as hepatitis and Lyme’s disease,
though caused by a single pathogen, can have exacerbated
symptoms when combined with a second pathogen [5,6]. In light
of the observed antigen-independent recruitment of activated
immune cells, an understanding of the trafficking and function of
immune cells beyond the traditional ‘‘single pathogen challenge’’
approach that most viral pathogenesis studies employ is para-
mount. Specifically in this report, we asked whether recruitment of
activated immune cells to virus-negative tissues occurs in
individuals who are challenged simultaneously with multiple
pathogens/antigens of differing tropism, and if so, whether this
affects the pathogenic outcome.
The studies reported here focus on the consequences of immune
cell recruitment into the CNS, as the unique environment of the
brain (e.g., restricted opportunity for inflammation, nonrenewable
cell populations) may make this organ system particularly
vulnerable. Moreover, given the number of CNS diseases of
unknown etiology that have an inflammatory component, this
work may be relevant to future translational efforts to deduce the
origins of such conditions.
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As a model, we infected permissive mice with neuron-restricted
measles virus (MV) and peripherally-restricted lymphocytic
choriomeningitis virus (LCMV). Measles is a member of the
family Paramyxoviridae; natural infection is restricted to humans and
primates. The identification of CD46 and SLAM as human MV
receptors allowed for the establishment of transgenic mice that
express these receptors in specific tissues. In NSE-CD46+ mice,
CD46 receptor transcription is restricted to CNS neurons by
control of the neuron-specific enolase (NSE) promoter [7].
Neuronal infection occurs in all NSE-CD46+ mice [8], though
CNS disease occurs only in neonates and immunocompromised
adults. Adult immunocompetent mice clear the infection without
pathogenic consequences, chiefly via interferon gamma (IFN-c)
[9].
Lymphocytic choriomeningitis virus is a member of the family
Arenaviridae, a natural pathogen of mice, and a historically
important tool in uncovering basic aspects of viral immunity
[10,11]. One of the notable attributes of LCMV is the diversity of
consequences that can be achieved in infected mice by varying
viral parameters (including the route of inoculation, dose, and viral
strain), as well as host features (including mouse strain, age, and
immunocompetence). Two of these outcomes are relevant here.
Following intraperitoneal (IP) inoculation of adult, immunocom-
petent mice, LCMV establishes infection of peripheral organs
including the spleen, liver, and kidney. By 4-6 days post-infection
(dpi), the host mounts a robust T cell response (principally CD8+ T
cells, with 80–95% of the splenocytes being specific for LCMV
[12]) that resolves the infection within 7–10 days in the absence of
overt disease. In contrast, delivery of as few as 1 plaque forming
unit (PFU) of LCMV into immunocompetent adults by an
intracerebral (IC) route results in lethal choriomeningitis within
6–7 dpi [13]. By this route, LCMV rapidly establishes infection of
the membranes of the brain, including the meninges, leptome-
ninges, and ependyma, as well as the cerebro-spinal fluid (CSF)-
producing choroid plexus cells within the ventricles. As with the
peripheral infection, virus-specific CD8+ T cells rapidly expand
and migrate to the infected tissues. In the case of an LCMV IC
infection, these cells migrate to the CNS, where they then cause
damage to the ventricular membranes, resulting in edema and
precipitous uncal herniation [14].
In this study, we have taken advantage of the unique tissue
tropism of transgene-restricted neuronal infection with MV and
route of inoculation-restricted peripheral infection with LCMV to
evaluate the pathogenic consequences following the recruitment of
activated, peripheral LCMV-specific lymphocytes to the CNS,
despite a lack of LCMV infection in this tissue. We show that upon
concomitant infection with these two viruses, activated immune
cells specific for LCMV are recruited to a ‘‘primed’’ CNS where
they trigger neurological disease in the absence of LCMV
infection.
Materials and Methods
Ethics statement
This study was carried out in accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health. The protocol was reviewed
and approved by the Fox Chase Cancer Center Institutional
Animal Care and Use Committee (Office of Laboratory Animal
Welfare assurance number: A3285-01).
Mice, virus and infections
Inbred NSE-CD46+, NSE-CD46+ mice on a recombinase-
activating gene-2 deficient background (RAG-2 KO) [15], and
NSE-CD46+ mice on a perforin deficient background (PFN
KO)[16], were maintained in the closed breeding colony at Fox
Chase. All animals were on the H-2b background. LCMV
Armstrong (LCMV-Arm; ATCC) was passaged in BHK-21
fibroblasts and plaque purified, and titers were determined on
Vero fibroblasts. MV-Edmonston (MV-Ed; ATCC) was also
passaged and titered on Vero cells.
Mice were infected IC along the midline with the indicated PFU
of LCMV-Arm, MV-Ed, or phosphate buffered saline (PBS) as a
control, in a total volume of 15–20 ml using a sterile 27-gauge
needle. LCMV was delivered by an IP route in a volume of 200 ml
using a sterile 25-gauge needle. All mice were anesthetized with
metofane prior to inoculation and were monitored daily for signs
of illness. For some experiments, weight change was determined
by establishing the pre-infection baseline and subsequently
calculating weight gain or loss. Moribund mice that lost .20%
of their original body weight were euthanized. For some
experiments, virus was inactivated by exposure to UV for 15 m;
inactivation was verified by subsequent plaque assay. For CD8
depletion experiments, 150 mg of CD8 depleting antibody
(purified at the FCCC hybridoma facility from hybridoma clone
2.43 [ATCC #TIB 210]) was injected IP 1d prior to infection and
every 7d thereafter throughout the course of study.
Quantitative RNA analysis
To isolate RNA from infected tissues, brains were snap-frozen
in liquid nitrogen and homogenized in TriReagent (Sigma).
Thereafter, RNA was purified and quality-tested by gel electro-
phoresis. Contaminating DNA was removed using TURBO
DNA-free (Ambion, Austin, TX). RNA was quantified using the
Agilent 2100 BioAnalyzer in combination with a RNA 6000 Nano
LabChip. RNA was reverse-transcribed using M-MLV reverse
transcriptase (Ambion) and a mixture of anchored oligo-dT and
random decamers. For each sample, 2 RT reactions were
performed with inputs of 100 and 20 ng. An aliquot of the cDNA
was used for 59-nuclease assays using Taqman chemistry. LCMV
Author Summary
There are many CNS diseases, including multiple sclerosis
and amyotrophic lateral sclerosis, which have an inflam-
matory component, though no direct link has been
established between incidence and a CNS-resident infec-
tious agent. We reasoned that peripheral immunogens
could play a role in CNS disease by inducing an immune
response that is ‘‘mis-targeted’’ to the brain. This
hypothesis was based on the immunological principle
that, while education and activation of naı¨ve cells is an
antigen-driven process, recruitment is primarily antigen-
independent. We developed a viral co-infection model
using measles virus (MV) as a CNS activator and recruiting
signal and lymphocytic choriomeningitis (LCMV) as a
peripheral immune response initiator. Co-infection with
both viruses resulted in significant morbidity and mortal-
ity, coincident with LCMV-specific CD8+ T cell trafficking to
the brain. Death occurred due to edema, despite an
apparent absence of LCMV antigens within the brain, and
pathogenesis was CD8+ T cell-dependent, but perforin-
independent. Thus, recruitment of peripherally activated
CD8+ T cells to the CNS can potentiate neuroinflammation.
This work raises the possibility that concomitant immune
challenges may be an important cause of the neuroin-
flammation of some human CNS diseases, perhaps
accounting for the inability to identify a discrete patho-
genic trigger within affected brain tissues.
CNS Immunopathology following Viral Co-infection
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specific primers, in combination with Universal Master mix, were
run on a 7900 HT sequence detection system (Applied Biosystems,
Foster City, CA). Cycling conditions were 95uC, 15m followed by
40 (2-step) cycles (95uC, 15s; 60uC, 60s). Relative quantification to
the control was done using the comparative Ct method. The values
plotted are the average of at least 2 PCR reactions, and were
normalized to actin.
Measles nucleoprotein: fwd -- CGCAGGACAGTCGAAG-
GTC,
rev -- TTCCGAGATTCCTGCCATG,
probe -- 6fam-TGACGCCCTGCTTAGGCTGCAA-bhq1.
LCMV nucleoprotein: fwd -- CTAACTATGGCTTGTAT-
GGCCAAA,
rev -- TAAAGCAAGCCAAGGTCTGTGA,
probe -- 6fam-CACAGACTCCGCTCAATGACGTTGTA-
CA-bhq1.
Actb: fwd -- CCAGCAGATGTGGATCAGCA,
rev -- CTTGCGGTGCACGATGG,
probe -- 6fam-CAGGAGTACGATGAGTCCGGCCCC-bhq1.
Histology and immunohistochemical analysis of mouse
tissues
For each timepoint, brains from 4–5 mice were removed and
either immersed in 10% formalin for paraffin embedding and
subsequent sectioning and staining with hemotoxylin/eosin, or
immersed in tissue embedding compound, snap-frozen in a dry
ice/isopentane bath and stored at 280uC for immunohistochem-
istry. Horizontal cryosections (10 mm) were air dried and stored at
280uC. On the day of staining, sections were fixed in ice-cold
95% ethanol, rehydrated in PBS, and blocked for 20 m with 0.1%
BSA/PBS, followed by an avidin and biotin block (Vector
Laboratories, Burlingame, CA). Rat anti-mouse CD4 (clone
RM4-5; 1:100; Pharmingen, San Diego, CA), or rat anti-mouse
CD8a/CD8b.2 antibodies (clones 53-6.7 and 53-5.8, respectively;
1:100 each; Pharmingen) were used to identify CD4+ and CD8+ T
lymphocytes. Sections were then incubated for 1 h at room
temperature with a biotinylated anti-rat IgG secondary antibody
at a 1:200 dilution (Vector). Sections labeled with biotinylated
antibodies were treated for 30 m with a streptavidin-peroxidase
conjugate (ABC Elite; Vector), followed by visualization with
diaminobenzidine (DAB; 0.7 mg/ml in 60 mM Tris) and urea
H2O2 (0.2 mg/ml), purchased as pre-weighed tablets (Sigma). All
cells were counterstained with hematoxylin and preserved with an
aqueous mounting medium. Uninfected tissues, use of a haplotype
matched primary antibody, or omission of the primary antibody
served as negative controls. For all histological analyses, at least 3
sections per brain were examined from 3 different horizontal
levels, and at least 4 mice per experimental group were assessed.
Flow cytometric analysis of brain infiltrates
On the indicated dpi, mice were deeply anesthetized with
400 ml 3.8% chloral hydrate in PBS, delivered IP. Once animals
were confirmed to be nonresponsive, the mice were perfused
with 30 ml PBS. Following perfusion, each brain and spleen was
removed and pressed through a nylon mesh cell strainer in PBS.
Dissociated tissue was run over a 30/70% discontinuous Percoll
gradient for 20 m at 4uC. Mononuclear cells (MNCs) were
recovered from the interface, washed with PBS, treated with
0.84% ammonium chloride to remove contaminating red blood
cells (RBCs) and washed again. Collected MNCs were counted
using a standard hemocytometer and plated into a v-bottom 96-
well plate for subsequent antibody staining for multicolor flow
cytometry. The following antibodies (eBioscience) were used:
PE-Cy5-CD8a, APC-Ax750-CD4, PE-CD3e, FITC-CD11c,
APC-CD161c (NK1.1), PB-CD19, PE-Cy5.5 Gr-1 (Ly-6G),
PE-Cy7-CD49b (DX5), Ax700-CD11b, APC-NP396 and APC-
GP33 tetramers (a generous gift from John Wherry, Univ.
Pennsylvania). Cells were allowed to incubate with antibody for
1 h at 4uC and then washed following the incubation period.
Pelleted, stained cells were resuspended and read in a BD LSR
II system. Percentages obtained from flow cytometry were
combined with hemacytometer counts in order to calculate total
cell numbers.
Cytotoxic T lymphocyte (CTL) reaction
CD46-MC57 or MC57 cells were infected, respectively, with
either MV or LCMV at a multiplicity of infection (MOI) of 1 for
1 h, or left uninfected, and further cultured for 2d. 36106 of these
target cells were then labeled with 35 ml 51Cr for 1 h at 37uC.
Single cell suspensions of splenocytes were isolated from mice
infected with LCMV IP 6d previously and incubated with 51Cr
labeled target cells for 6 h at 37uC. Effector and targets cell
concentrations were calculated and cells were added at ratios of
100:1, 50:1, and 10:1 in a total reaction volume of 200 ml, with
each condition in triplicate. DMEM and 1% IGEPAL (Sigma)
were used in place of splenocytes for calculating spontaneous
release and maximum release, respectively. Following effector/
target cell co-culture, 40 ml of collected supernatant for each
condition was diluted in 60 ml MicroScint scintillation fluid (Perkin
Elmer). Released 51Cr was measured in a gamma counter with the
percentage of specific 51Cr release being calculated by the
following formula: [(experimental release – spontaneous release) /
(maximum release – spontaneous release)] x 100.
Blood-brain barrier permeability and edema
measurements
At 7d post-inoculation with LCMV-Arm IP, MV-Ed IC or
PBS, mice were deeply anesthetized with 400 ml 3.8% chloral
hydrate in PBS, delivered IP. Once animals were confirmed to be
nonresponsive, 200 ml of a 2% Evan’s Blue solution was then
administered transcardially; 2 m post-injection, the mice were
perfused with 30 ml PBS. For Evan’s blue quantification, brains
were dissected, placed in test tubes, snap-frozen in liquid nitrogen
and stored at 280uC. Brain tissues were slowly thawed at RT,
homogenized in 1 ml N,N-dimethyl formamide and incubated at
50uC for 2d. Following centrifugation at 2700 g for 10 m, the
absorbance of the supernatant containing extracted Evan’s blue
was measured in a spectrophotometer at 620 nm. Each
absorbance reading was normalized to wet brain weight. Evan’s
Blue uptake into the tissues of each infected animal was divided
by the average uptake detected in similar tissues from PBS
control mice and the results expressed as fold induction.
Statistical significance was determined using the Wilcoxon
signed-rank test.
To determine brain water weight, mice were euthanized with
isofluorane at 7d post-inoculation with LCMV-Arm IP, MV-Ed
IC or PBS. For CD8+ T cell depletion experiments, 150 mg of
CD8 depleting antibody (purified at the FCCC hybridoma facility
from hybridoma clone 2.43 [ATCC #TIB 210]) was injected IP
1d prior to infection. Brains were removed, placed in test tubes
and then desiccated in a vacuum oven for 24 h at ,80uC at
15 mm Hg. Brain weights were determined both prior to and
immediately following desiccation, with relative percent water
weight determined by the following formula: [(wet weight - dry
weight)/wet weight] x 100. Water weight of the brain of each
infected animal was divided by the average water weight detected
in similar tissues from PBS control mice, and the results expressed
CNS Immunopathology following Viral Co-infection
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as percentage change. Statistical significance was determined using
the Wilcoxon signed-rank test.
Results
Co-infection with neurotropic and viscerotropic viruses
leads to unique neuropathogenesis
Infection of mice with LCMV by an IP route generates a robust
CD8+ T cell response that clears the virus within 7–10 dpi in the
absence of overt disease. Similarly, MV infection of transgenic
mice expressing a human measles receptor targeted to CNS
neurons (NSE-CD46+ mice) results in activation of a protective
adaptive response that resolves the infection in a similar
timeframe, and without concomitant illness. Because these
infections are tissue-restricted (LCMV to peripheral tissues and
MV to the CNS), we explored the parameters of viral clearance,
immune cell trafficking, and pathogenesis in mice infected
simultaneously with both pathogens (Figure 1A).
NSE-CD46+ mice were challenged concurrently with MV by an
IC route (16104 PFU) and LCMV by an IP route (26105 PFU)
and monitored daily for weight loss and overt signs of illness. As
shown in Figure 1B and Table 1, no weight loss was observed in
any of the singly infected mice or uninfected controls over a 34d
observation period and all mice appeared healthy throughout this
Figure 1. Co-infection model and pathogenic outcome. (A) NSE-CD46+ transgenic mice survive MV IC challenge and mount an immune
response that peaks between 7–9 dpi (left panel) [9]. LCMV, a natural mouse pathogen, is restricted to peripheral organs (spleen, liver, kidney,
pancreas) following IP inoculation (middle panel); all mice survive, and peak immunity also occurs between 7–9 dpi [12]. In contrast, ,50% of mice
infected with both MV IC and LCMV IP (doubly infected; DI) succumbed to virus-induced seizures (right panel). (B) Baseline weights of all mice were
obtained, daily weights were calculated, and weight gain or loss was determined. Mice challenged with PBS (black triangles), MV alone (black circles),
or LCMV alone (asterisks) showed modest increases in weight over the 34d observation period (.10 mice/group). The cohort of mice infected with
both LCMV and MV were divided into two groups based on the severity of the illness that was observed: animals with mild illness (white diamonds)
and with severe illness and mortality (white squares). Statistics were performed using the Wilcoxon Signed Rank Test. #: p = 0.0002; ##: p,0.0001.
doi:10.1371/journal.ppat.1002462.g001
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timecourse. In contrast, approximately half of the mice challenged
with both LCMV and MV showed dramatic weight loss
(Figure 1B, white squares; Table 1, group 3), leading to death
by 8–10 dpi. Within this group, all animals showed overt signs of
CNS disease, including ataxia, tremors, and a hunched (kyphotic)
and ruffled appearance. In the terminal stages of disease, mice
developed severe seizures lasting .10s per episode; death was
always coincident with these seizures. The co-infected mice that
did not develop severe disease showed little change in weight
(Figure 1B, white diamonds), but most did show moderate illness,
including slight ataxia. Of note, most of the severely sick mice
began to show signs of weight loss and illness within 3–4 dpi,
whereas the mice that would go on to have mild disease and
survive appeared asymptomatic at this timepoint.
To address whether the pathogenesis resulting from co-infection
was attributable to increased viral load, we reduced the dosages of
both MV and LCMV by 10-fold; however, identical results were
obtained (Table 1, group 4). Moreover, when UV-inactivated
MV was administered instead of replication-competent virus, no
disease or weight loss was observed (Table 1, group 5).
Interestingly, however, challenge of mice with UV-inactivated
LCMV did result in morbidity in approximately 25% of infected
mice, indicating that replicating LCMV was not required to elicit
the pathogenic phenotype (Table 1, group 6). Finally, we found
that the timing of the infections was critical: if the infections were
separated temporally (7d and 30d tested, in which MV was given
first, followed by LCMV), no pathogenesis was observed (Table 1,
groups 7 and 8). Collectively, these data indicate that concurrent
challenge of mice with two viruses triggers a novel pathogenic
outcome that is not observed with either virus alone.
Illness in co-infected mice is not attributable to mouse
characteristics or to changes in viral tropism
To determine the basis of fatal neurological disease in some co-
infected mice and to define the factors that govern the differential
pathogenic response, we first considered possible differences in the
infected mice themselves. Consequently, we evaluated whether sex
or age distinguished mice that developed severe CNS disease from
those that survived the milder disease. Mice of both sexes between
3–6 months of age were co-infected, and neither age nor sex
correlated with pathogenic outcome (data not shown).
We next asked if co-infection altered MV or LCMV biology
with respect to titer, tropism, or rates of viral clearance. As shown
in Figure 2A, which depicts quantitative RT-PCR results from
co-infected mice at 4 dpi, MV RNA remained restricted to the
CNS and LCMV RNA to peripheral tissues, including the spleen
and liver. Likewise, no evidence of LCMV immunopositive cells
was found by immunohistochemistry in brains of co-infected mice
(data not shown). When mice were evaluated at 2, 7, 12 and
30 dpi, though viral loads differed as these viruses were being
cleared, the same tissue restriction was observed (data not shown).
Moreover, the viral load of MV in the CNS was not appreciably
different between singly and co-infected mice (Figure 2B). RNase
protection assays (TNFa, TNFb, CCL2, CCL3, CCL4, CCL5,
CXCL2, CXCL10, CXCR3, IFNb, IFNc, IFNcR, VCAM1, IL-
4, IL-12, IL-15, IL-18, iNOS) were performed and no significant
change, in either levels or profile, was observed between MV
infection alone and co-infection or between symptomatic and
asymptomatic co-infected mice (data not shown). These data
indicate that key aspects of the viral life cycle for both MV and
LCMV, including tissue tropism and viral load, were not changed
upon co-infection.
Massive infiltration of CD8+ T cells into brains of co-
infected mice
We next evaluated the host immune response within brains of
infected mice, first using standard immunohistochemistry for the
presence of both CD4+ and CD8+ T cells in horizontal brain
sections, followed by ex vivo isolation of brain-infiltrating immune
cells combined with flow cytometry and hemocytometer counts.
Representative horizontal plane images are shown in Figure 3A.
As published previously [9,17], NSE-CD46+ transgenic mice
infected with MV IC show substantial, and approximately
equivalent, infiltration of both CD4+ and CD8+ T cells at 7 dpi
(Figure 3A, center panels). As expected, T cells typically
accumulate in regions where MV antigen is prevalent (data not
shown). Brains from LCMV-infected mice had no evidence of T
cell infiltration into the CNS (Figure 3A, left panels), because the
CNS is not a target organ for infection by LCMV via the IP route
(Figure 2A). When mice were challenged with both LCMV and
MV and examined histologically at 7 dpi (Figure 3A, right
panels), the number and proportion of CD8+ T cells in the CNS
was steeply elevated compared to singly infected mice (Figure 3A,
3B), increasing from approximately 14,000 cells in MV-infected
brains to 170,000 cells in brains of mice challenged with both
viruses. This represents a 12-fold increase over the single MV
Table 1. Morbidity following viral challenge.
Group MV dose (PFU)* LCMV dose (PFU)** Interval (d)*** n % morbidity****
1 16104 none n/a 20 0
2 none 26105 n/a 20 0
3 16104 26105 n/a 68 44
4 16103 26104 n/a 17 35
5 16104 (UV) 26105 n/a 11 0
6 16104 26105 (UV) n/a 13 23
7 16104 26105 7 16 0
8 16104 26105 30 12 0
*Mice were inoculated with the specified dose via intracerebral inoculation in a volume of 30 ul. For group 5, virus was inactivated by exposure for 15 min to a UV light
source and absence of infectious virus verified by plaque assay.
**Mice were inoculated with the specified dose via intraperitoneal inoculation in a volume of 200 ul.
***For interval studies, mice were infected with MV, rested for the indicated number of days, and then infected with LCMV.
****Morbidity was determined by either weight loss greater than 20% and/or seizures, ataxia or persistent tremors.
doi:10.1371/journal.ppat.1002462.t001
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infection and a .250-fold increase compared to uninfected mice.
As shown in the bottom right panel of Figure 3A, CD8+ T cells
were found distributed throughout the brain, though somewhat
concentrated in patches that correlated with sites of MV
replication (data not shown), as well as surrounding vascular
structures, ventricles and meninges. While there was a range in the
number of lymphocytes isolated from individual brains, the
increase in CD8+ T cells was observed in all co-infected mice
that were tested, regardless of illness (Figure 3B). In contrast, the
number of CD4+ T cells was only slightly increased in co-
challenged mice, compared to levels seen in MV-infected mice
alone (avg. 13,500 vs. 22,000; Figure 3A, 3B). Similarly, flow
cytometry revealed no significant increases in other immune cell
populations (B cells, NK cells, NKT cells, macrophages,
neutrophils, dendritic cells; data not shown). Thus, the lethal
CNS disease that occurs in approximately half of the co-infected
mice is not simply attributable to the abundance of infiltrating cells
within the brain parenchyma, and appears to involve CD8+ T
cells.
LCMV-specific CD8+ T cells are found in the brains of
co-infected mice
LCMV potently activates CD8+ T cells; thus, we used LCMV-
specific tetramers to determine the proportion of CNS-infiltrating
CD8+ T cells of LCMV-specificity. Tetramers specific for the two
major LCMV epitopes on the H-2b background (GP33 and
NP396) were employed (provided by Dr. John Wherry). As shown
in the representative data in Figure 4A, right panels, 8% (mean:
6.1 6 2.0%) and 17% (mean: 15.2 6 3.8%) of the lymphocytes
extracted from co-infected brains were CD8+ T cells specific for
LCMV GP33 and NP396, respectively. Based on these two
immunodominant peptides, .35% (37.6 6 5.8%) of the total
infiltrating CD8+ T cells (.21% of the total brain-infiltrating
immune cell population) were specific for LCMV within the brains
of co-infected mice. This is likely a substantial underestimate, as
this does not account for T cells specific for minor LCMV
epitopes. LCMV tetramers did not label any lymphocytes isolated
from brains of mice infected with MV alone, indicating that there
is little to no cross-reactivity between LCMV and MV, as
measured by this assay. This was further supported in standard
CTL assays, in which splenocytes isolated from mice infected with
LCMV IP did not recognize MV-infected target cells (Figure 4B).
The manifestation of CNS disease in co-infected mice is
identical to that seen in mice challenged with LCMV by
an intracerebral route
Interestingly, the posture of mice that die following co-infection
is identical to that seen in mice challenged with LCMV by an IC
route (Figure 5A). IC LCMV infection of immunocompetent
mice with as few as 1 PFU results in overt signs of illness by
,6 dpi, including ruffled fur, ataxia and tremors, which invariably
lead to seizures and death by 6.5–7 dpi. The decerebrate posture
following LCMV death is unique to LCMV, as mice that succumb
to other CNS infections (such as RAG-2 KO mice following MV
infection; Figure 5A, second panel) or mice infected with
poliovirus (data not shown), do not develop seizures or a similar
post-mortem posture.
Recently, we showed that death following LCMV IC challenge
coincided with apparent compression of the brain against the skull
[14]. Moreover, all mice dying of LCMV by the IC route had
unilateral pupillary dilation (mydriasis), which is likely attributable
to uncal herniation of brain tissue through the foramen magnum.
Similar observations were found in all moribund mice that were
infected with both LCMV IP and MV IC (Figure 5B, right
panels), implying a common mechanism of disease.
It is well established that mortality following IC challenge with
LCMV is mediated by CD8+ T cells [18,19]. Thus, given the
massive infiltration of CD8+ T cells into the brains of co-infected
animals, combined with the observed similarities in gross
pathology between the co-infected mice that die and those
challenged with LCMV IC, we next elucidated the role that
CD8+ T cells play in the neuropathogenesis observed in the co-
infected animals.
CD8-depleted mice exhibit delayed pathogenesis
CD8-depleted mice were challenged with both MV IC and
LCMV IP (Figure 6A). As expected, CD8+ T cell depletion
delayed the onset of pathogenesis by approximately 6d, indicating
that CD8+ T cells are important for the mechanism of
pathogenesis. While some co-infected CD8-depleted mice did
succumb at later timepoints, they displayed symptoms similar to
MV IC infection of NSE-CD46+/RAG-2 KO mice (hunched/
kyphotic posture and ruffled appearance) and not those observed
Figure 2. Tissue distribution of LCMV and MV in co-infected
mice. (A) RNA was purified from the indicated tissues of co-infected
mice at 4 dpi and amplified by quantitative RT-PCR for MV (black bars,
scale on left) or LCMV (gray bars, scale on right). BD = below detection.
(B) The extent of MV load was assessed in brains of mice infected with
MV alone or with both MV and LCMV at 7 dpi. Data points represent
individual mice, with averages shown as horizontal lines.
doi:10.1371/journal.ppat.1002462.g002
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with symptomatic co-infected immunocompetent mice (seizures
leading to death and the characteristic decerebrate posture).
Furthermore, a proportion of CD8-depleted animals challenged
with MV IC alone also succumbed with MV-like symptoms,
confirming that, in the absence of CD8+ T cells, mice are
susceptible to an intracerebral MV infection.
Figure 3. Immune response within the brains of co-infected mice. (A) Brains of mice infected with LCMV IP alone (left panels), MV IC alone
(center panels), or both viruses (right panels) were harvested 7 dpi and serial sections were immunostained for either CD4+ T cells (top panels) or CD8+ T
cells (bottom panels) using DAB (red/brown staining) and counterstained with hematoxylin (gray/light blue staining). Original magnification =
100X. (B) Brains were removed from the indicated mice at 7 dpi and homogenized. Mononuclear cells were extracted and subjected to staining using
fluorophore-conjugated antibodies, followed by flow cytometry. Using this flow cytometry data, together with cell counts obtained using a
hemocytometer, the total number of CD4+ and CD8+ T cells, as well as the percent of total CNS infiltrate, was calculated. Values for individual mice are
shown, with averages shown as horizontal bars. Statistics were performed using the Wilcoxon Signed Rank test. ##: p,0.0001; NS: not significant.
doi:10.1371/journal.ppat.1002462.g003
Figure 4. LCMV-specific CD8+ T cells are found within the brains of co-infected mice. (A) T cells were isolated from brains of mice that were
either uninfected (left panels), infected with MV IC alone (center panels), or infected with both LCMV IP and MV IC (right panels), as described in
Figure 3. Cells were dual stained for CD8 (x-axis) and for one of two immunodominant LCMV epitopes (y-axis), using specific tetramers (GP33: top
panels; NP396: bottom panels). (B) A standard 51Cr release assay was performed by incubating effector splenocytes from LCMV-infected mice (6 dpi)
with uninfected (diamonds), MV-infected (squares), or LCMV-infected (triangles) target cells at the indicated ratios. Released 51Cr was measured in a
gamma counter and specific release was calculated.
doi:10.1371/journal.ppat.1002462.g004
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To elucidate the mechanism of pathogenesis mediated by CD8+
T cells in the co-infection model, we infected mice which lack the
pore-forming protein perforin, which is required by cytotoxic
lymphocytes to mediate granzyme-driven lysis of target cells. Co-
infected NSE-CD46+/PFN KO mice succumbed in a similar
fashion to NSE-CD46+ immunocompetent mice, both temporally
and symptomatically (Figure 6B). This indicates that perforin
does not a play a central role in CD8+ T cell-mediated
pathogenesis in co-infected mice. At later time points (.15 dpi),
NSE-CD46+/PFN KO animals succumbed somewhat more
rapidly than NSE-CD46+ immunocompetent mice; however, they
did so with symptoms identical to those seen during MV infection
of immunocompromised NSE-CD46+/RAG-2 KO mice [9]. This
decline may be attributable to the observation that PFN KO
animals succumb to a LCMV IP alone challenge at later
timepoints, whereas immunocompetent mice survive such a
challenge.
Edema correlates with morbidity in co-infected mice
In LCMV IC-challenged mice, brain herniation results from an
increase in intracranial pressure, which causes the brain tissue to
shift from an area of higher pressure to one of lower pressure. To
determine whether the co-infected mice were dying from brain
herniation (as suggested by their postmortem posture in a CD8-
dependent fashion), we examined various mechanisms that could
result in increased intracranial pressure.
Edema increases intracranial pressure, which can then lead to
herniation. To directly ascertain if moribund mice had evidence of
cerebral edema (elevated brain water weight), brains were
removed at 7 dpi from: i) control PBS IC mice, ii) mice that
were challenged with LCMV by an IP route (not expected to lead
to CNS water volume changes), iii) MV IC (which results in
immune cell infiltration, but no CNS disease), or iv) mice infected
with both viruses. For the co-infected group, mice were further
separated into those with severe (fatal) illness and those with the
milder, nonfatal disease. Mice challenged singly with either
LCMV IP or MV IC had water volume values that were not
appreciably changed from uninfected or PBS-challenged mice
(Figure 7A). (Water weight raw values ranged from 72–81%).
Similarly, co-infected mice with mild disease showed no
substantial edema (average of 77%, and a range of 73–79%). In
sharp contrast, severely sick, co-infected mice showed a statistically
significant increase in water volume (.7% over baseline), with an
average of 83%, ranging from 80–87%, strongly suggesting that
edema is mechanistically linked to mortality in this model system.
As further evidence of a role for CD8+ T cells in this process,
CD8-depleted mice did not show a significant increase in edema.
We also evaluated the integrity of the blood-brain barrier (BBB),
as determined by extravasation of albumin-bound Evan’s Blue into
the brains of infected mice, as a possible cause of increased brain
edema and resulting herniation. As shown, all singly infected mice
and co-infected mice with mild symptoms showed negligible
increases in Evan’s Blue levels, indicative of an intact barrier, at
7 dpi (Figure 7B). Severely sick, co-infected mice showed only
modest BBB permeability. Though there was variability in the
values within the severely sick group, with some mice exhibiting
high levels of Evan’s Blue, there was no statistical significance in
the overall increase in permeability. This is consistent with the
LCMV IC model: while the blood-brain barrier is permeabilized
in many of these mice, the changes do not correlate with the onset
of disease.
Finally, we assessed the histopathology in brains of moribund
mice to determine potential causes for the observed cerebral
edema (Figure 7C). In all animals evaluated, inflammation within
the choroid plexus (i) and meninges (ii) was found, along with
evidence of parenchymal damage, as determined by the extensive
deposition of hemosiderin within the parenchyma (iii, arrows),
indicative of capillary bleeding. Interestingly, the moribund co-
infected animals had greater levels of meningitis than the animals
which survived challenge with both viruses (data not shown).
Collectively, these data suggest that the processes that mediate
pathogenesis in co-infected NSE-CD46+ mice are similar to those
observed in mice challenged with LCMV by the lethal IC route.
However, unlike the LCMV IC infection in which all mice
succumb, co-infection results in mortality in only approximately
50% of infected individuals. Specifically, disease is CD8-
dependent, yet perforin-independent, and correlates with in-
creased cerebral edema and evidence of both meningitis and
encephalitis.
Discussion
This paper describes the development of a mouse model of
tissue-restricted, simultaneous viral challenges: MV is restricted to
CNS neurons due to transgenic specification of the receptor, and
LCMV is limited to peripheral tissues due to the route of
inoculation. While single infection with either virus alone results in
immune-mediated protection in the absence of disease, co-
Figure 5. Postmortem examination of neuropathogenesis in
co-infected mice shows signs of brain herniation. (A) Represen-
tative mice infected with LCMV IC (left panel), MV IC (in NSE-CD46+
RAG-2 KO mice) (center panel), and both LCMV and MV (right panel) are
shown exhibiting characteristic, post-mortem postures. (B) The scalp
was removed from moribund co-infected mice or PBS treated controls
to expose the skull; photographs were taken of the rear of the brain and
cervical spinal cord. Note compression of white matter (cerebellum)
against the posterior skull in co-infected animals. Mice were also
examined for unilateral pupillary dilation (mydriasis) (seen here in
mouse’s left eye; white arrow). Photographs are representative of 5 to
10 mice per group.
doi:10.1371/journal.ppat.1002462.g005
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infection results in a high degree of morbidity and mortality,
apparently triggered by migration of LCMV-specific CD8+ T
lymphocytes into the MV-infected CNS.
The pathogenesis observed in moribund co-infected mice is
indistinguishable from that seen in mice challenged with LCMV
by an IC route. We previously showed that disease in LCMV IC-
infected mice is attributable to increased brain water weight
(edema) and reactive periventricular disease, culminating in
physical manifestations consistent with uncal herniation (seizures,
decerebrate posture, mydriasis) [14]. In the present study, similar
increases in edema were observed in moribund, co-infected mice.
While changes in blood-brain barrier integrity were also noted in
these mice (as also noted in LCMV IC infected mice), increased
permeability was neither significant nor consistently correlated
with the timing of disease. Therefore, though blood-brain barrier
damage may contribute to neuropathogenesis, it does not appear
Figure 6. Pathogenesis in co-infected mice is CD8+ T cell dependent and perforin independent. (A) NSE-CD46+ mice were injected IP with
150 mg of CD8-depleting antibody (clone 2.43), or an isotype control antibody, and challenged with MV IC alone (closed/open squares), LCMV IP
alone (closed/open circles), or both MV IC and LCMV IP (closed/open triangles). Mice were monitored daily for survival. (B) Mice of the indicated
genotypes were challenged with MV IC alone (closed/open squares), LCMV IP alone (closed/open circles), or both MV IC and LCMV IP (closed/open
triangles) and monitored daily for survival.
doi:10.1371/journal.ppat.1002462.g006
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to be the precipitating cause of mortality in our mouse model.
Importantly, active infection of the CNS was a prerequisite for
disease, as instillation of the CNS with UV-inactivated MV did not
result in either elevated T cell recruitment or neuropathogenesis.
Thus, the acute CNS infection (which is pathogenically inert when
delivered alone) likely induces recruitment signals, including
chemokines [20], and adhesion molecules on barrier endothelium,
that then aid lymphocyte recruitment. Of relevance, the receptor
for CXCL10, CXCR3, is expressed by a majority of activated,
LCMV-specific CD8+ T cells, which would presumably allow
them to traffic toward the MV-initiated recruitment signal [21,22].
These chemoattractant signals would be expected to recruit all
activated immune cells, regardless of specificity. While other
models have shown that lymphocytes can be recruited to tissues
that do not express cognate antigen [4,23,24], to our knowledge,
the MV/LCMV co-infection model is the first to show that this
phenomenon can have pathogenic consequences.
While the parallels between mortality following co-infection and
the classic LCMV IC infection allowed us to define neuroana-
tomical events that were consistent with mortality, the precise
mechanism by which LCMV-specific T cells trigger damage
within the CNS remains unknown. It does not seem likely that the
massive infiltration of T cells into the brain can, alone, account for
disease, as there was no direct correlation between total
lymphocyte counts in the CNS and disease severity. Nevertheless,
the possibility that migration of T cells to a particular site within
the brain may contribute to enhanced vulnerability cannot be
excluded. Using immunodepleted and immune knockout mice, it
is clear that the neuropathogenesis following co-infection in this
model is dependent on CD8+ T cells, but independent of their
effector function involving perforin.
A key question that is the basis of our ongoing work is to define
what LCMV-specific T cells ‘‘see’’ to trigger disease, since we
detected no cross-reactivity between MV and LCMV, and by
multiple methods, no LCMV RNA or proteins were detected in
the CNS at any timepoint tested, from 2–30 dpi. Moreover, co-
infection with UV-LCMV IP together with MV IC triggered
neuropathogenesis, indicating that replicating LCMV need not be
present in the CNS. Classically, the expression of effector functions
by CD8+ T cells is reliant on the recognition of antigen. However,
together with IFN-c, the innate cytokines, IL-12, IL-18, IL-23 and
IL-27, have all been shown to be potent activators of T cells that
act in an antigen-independent manner, as well as independent of
TCR ligation and signaling [25,26]. Binding of these interleukins
to their respective receptors on T cells alone causes these CD8+ T
cells to become activated and release IFN-c and TNF-a. These
early functions of CD8+ T cells are important components in the
host response to such pathogens as influenza A virus, Lysteria
monocytogenes, Cryptosporidium parvum, and tumors [26–30]. Together,
these data suggest that CD8+ T cells may indeed play a role in
immunopathogenesis if they have been independently activated
and then ‘misrecruited’ to another, independent site of infection.
Neither changes in tropism nor changes in the extent of
infection of either virus were seen to change following co-infection.
Figure 7. Edema, but not blood brain barrier, changes correlate with pathogenesis in co-infected mice and is dependent on CD8+ T
cells. (A) Brains were removed 7 dpi from mice infected as indicated and weighed before and after dehydration in a vacuum oven. Total water
weight was determined for each mouse and normalized to values from PBS IC mice; averages are shown as grey bars, with standard deviation
indicated. Statistics were performed using the Wilcoxon Signed Rank test. #: p = 0.03; NS: not significant. (B) Mice, infected and treated as indicated,
were anesthetized at 7 dpi and injected with Evan’s Blue, followed by saline perfusion. Total Evan’s Blue that diffused into the brain was determined
by spectrophotometry following brain homogenization and clarification. Data were normalized to values from mice inoculated with PBS IC, and
averages are shown as gray bars, with standard deviation indicated. Statistics were performed using the Wilcoxon Signed Rank test. NS: not
significant. (C) Representative photomicrographs were taken from brain sections of mice with severe disease following co-infection with LCMV IP and
MV IC. Evidence of choroid plexus inflammation (i), meningitis (ii), and hemosiderin deposition, indicative of capillary bleeding (iii), are shown.
Original magnifications: A, B = 640X; C = 800X.
doi:10.1371/journal.ppat.1002462.g007
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While our PCR-based and IHC-based studies found no evidence
of LCMV infection within the brain, work by others suggests that
brain endothelial cells and epiplexus cells can present antigen in
the absence of direct infection, similar to cross-presentation by
antigen presenting cells [31–33]. Thus, it is possible that in these
co-infected animals, brain endothelial cells or epiplexus cells
present LCMV epitopes picked up from the CSF, in the absence of
direct infection. Evaluation of this mechanism as a possible cause
of neuropathogenesis is an ongoing effort, and adoptive transfer
studies using activated LCMV-specific CD8+ T cells into a MV-
infected recipient are underway. However, we are cautious about
a result of a lack of neuropathogenesis in these experiments, as a
‘‘primed’’ microenvironment within the periphery may be an
important component in activation of such cells.
What general implications can be inferred from these results?
Mouse models have been essential for the study of viral
pathogenesis, both in aiding our understanding of the viral life
cycle in vivo and in revealing critical aspects of immune response
induction, recruitment, and function. Nevertheless, the "single-
challenge" approach that most viral pathogenesis studies employ--
in which immunologically naı¨ve adult animals are inoculated with
only one pathogen and evaluated thereafter--does not approxi-
mate the complexity of immune history or host responses to
concurrent immune challenges that occur in humans.
A prominent example of coinfection with enhanced pathology is
human immunodeficiency virus (HIV) and hepatitis C virus. For
pathogen combinations such as this, the mechanism of increased
pathology is well understood: Pathogen A causes immunosuppres-
sion of the infected host, thereby setting up a permissive
environment for Pathogen B to establish an unrestricted infection
[34]. The issue of immunosuppression is one that we have not
explored, even though it is known that MV reduces responses to a
co-infecting agent (i.e. HIV) [35]. At this point, we do not believe
that this is a major confounder for our experiments since all arms
of the immune response examined in our model are either
increased or remained at baseline, when compared to either single
infection alone. For other diseases, such as Burkitt’s lymphoma,
polymicrobial infections (Epstein-Barr virus (EBV) and Plasmodi-
um falciparum malaria) are clearly associated with the disease
outcome, but the causative mechanism is still elusive [36]. Thus,
polymicrobial infections – especially in developing regions of the
world – are common, though how these pathogens and their
respective immune responses interact to result in pathogenic
outcomes remains unknown.
While making direct connections between this model system
and human diseases would be premature, a similar phenomenon
could account for both the reported increase in inflammatory cells
found in the brain of patients presenting with MS and ALS [37–
40], as well as the lack of consistent and convincing presence of
any specific pathogen in the brains of affected individuals [41–44].
A large number of CNS diseases of unknown etiology have been
proposed to have viral triggers [45–48], though no single
pathogenic agent has been linked with any chronic CNS disease,
perhaps because it is generally assumed that the viral trigger must
be co-localized with the observed damage. Our co-infection model
of immune cell recruitment suggests that this may not need to be
the case – the virus infection and damage sites may be spatially
distant, provided that a recruiting signal (e.g., a chemokine
gradient) is present within the CNS.
While our studies focused on viral pathogens, the results can be
considered more broadly in terms of any agent or situation that
can trigger an immune response. For example, concurrent
immune responses to other antigens (e.g., tumors, allergens,
autoantigens) might also contribute to pathology resulting from
infection-irrelevant immune effector trafficking. In summary,
while single-pathogen mouse models will continue to be powerful
tools to explore the induction and function of immune cells and
their mediators, more complex animal models, which consider
both pathogenic and non-pathogenic triggers of host immunity,
will be required to fully reveal the diversity of ways by which
immune-mediated neurological diseases occur.
Acknowledgments
The authors gratefully acknowledge David Wiest, Luis Sigal, Sid
Balachandran, Alicia Holmgren and Sarah Cavanaugh for critical input
on this manuscript.
Author Contributions
Conceived and designed the experiments: CMM KJO’R GFR. Performed
the experiments: CMM KJO’R. Analyzed the data: CMM KJO’R MC
GFR. Contributed reagents/materials/analysis tools: MC GFR. Wrote the
paper: CMM KJO’R GFR.
References
1. Antel JP, Owens T (1993) The attraction of adhesion molecules. Ann Neurol 34:
123–124.
2. Butcher EC, Picker LJ (1996) Lymphocyte homing and homeostasis. Science
272: 60–66.
3. Mackay CR (1993) Homing of naive, memory and effector lymphocytes. Curr
Opin Immunol 5: 423–427.
4. Chapman TJ, Castrucci MR, Padrick RC, Bradley LM, Topham DJ (2005)
Antigen-specific and non-specific CD4+ T cell recruitment and proliferation
during influenza infection. Virology 340: 296–306.
5. Bakaletz LO (2004) Developing animal models for polymicrobial diseases. Nat
Rev Micro 2: 552–568.
6. Brogden KA, Guthmiller JM, Taylor CE (2005) Human polymicrobial
infections. Lancet 365: 253–255.
7. Rall GF, Manchester M, Daniels LR, Callahan EM, Belman AR, et al. (1997) A
transgenic mouse model for measles virus infection of the brain. Proc Natl Acad
Sci USA 94: 4659–4663.
8. Lawrence DMP, Vaughn MM, Belman AR, Cole JS, Rall GF (1999) Immune
response-mediated protection of adult but not neonatal mice from neuron-
restricted measles virus infection and CNS disease. J Virol 73: 1795–1801.
9. Patterson CE, Lawrence DM, Echols LA, Rall GF (2002) Immune-mediated
protection from measles virus-induced central nervous system disease is
noncytolytic and gamma-interferon dependent. J Virol 76: 4497–4506.
10. Borrow P, Oldstone MBA (1997) Lymphocytic choriomeningitis virus. In:
Nathanson N, ed. Viral Pathogenesis. Philadelphia, PA: Lippincott-Raven. pp
593–627.
11. Buchmeier MJ, Zajac AJ (1999) Lymphocytic choriomeningitis virus. In:
Ahmed R, Chen I, eds. Persistent Viral Infections. Chicester, NY: John Wiley &
Sons. pp 575–605.
12. Masopust D, Murali-Krishna K, Ahmed R (2007) Quantitating the magnitude
of the LCMV-specific CD8 T cell response: it’s even bigger than we thought.
J Virol 81: 2002–2011.
13. Kang SS, McGavern DB (2008) Lymphocytic choriomeningitis infection of the
central nervous system. Front Biosci 13: 4529–4543.
14. Matullo CM, O’Regan KJ, Hensley H, Curtis M, Rall GF (2010) Lymphocytic
choriomeningitis virus-induced mortality in mice is triggered by edema and
brain herniation. J Virol 84: 312–320.
15. Shinkai Y, Rathbun G, Lam K (1992) RAG-2 deficient mice lack mature
lymphocytes owing to the inability to initiate V(D)J rearrangement. Cell 68:
855–864.
16. Kagi D, Liedermann B, Burki K, Seller P, Odermatt B, et al. (1994) Cytotoxicity
mediated by T cells and NK cells is greatly impaired in perforin-deficient mice.
Nature 369: 31–37.
17. Lawrence DMP, Patterson CE, Gales TL, D’Orazio JL, Vaughn MM, et al.
(2000) Measles virus spread between neurons requires cell contact but not CD46
expression, syncytium formation or extracellular virus production. J Virol 74:
1908–1918.
18. Buchmeier M, Welsh R, Dutko F, Oldstone M (1980) The virology and
immunobiology of LCMV infection. Adv Immunol 30: 275–331.
19. Oldstone MBA, Southern PJ (1993) Trafficking of activated CTL into the CNS:
use of a transgenic model. J Neuroimmunol 46: 25–31.
CNS Immunopathology following Viral Co-infection
PLoS Pathogens | www.plospathogens.org 12 December 2011 | Volume 7 | Issue 12 | e1002462
20. Patterson CE, Daley JK, Echols LA, Lane TE, Rall GF (2003) Measles virus
infection induces chemokine synthesis by neurons. J Immunol 171: 3102–3109.
21. Christensen JE, de Lemos C, Moos T, Christensen JP, Thomsen AR (2006)
CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in
immune surveillance of the lymphocytic choriomeningitis virus-infected central
nervous system. J Immunol 176: 4235–4243.
22. Christensen JE, Nansen A, Moos T, Lu B, Gerard C, et al. (2004) Efficient T-cell
surveillance of the CNS requires expression of the CXC chemokine receptor 3.
J Neurosci 24: 4849–4858.
23. Joncker NT, Helft J, Jacquet A, Premel V, Lantz O (2006) Intratumor CD4 T-
cell accumulation requires stronger priming than for expansion and lymphokine
secretion. Cancer Res 66: 5443–5451.
24. Joncker NT, Marloie M-A, Chernysheva A, Lonchay C, Cuff S, et al. (2006)
Antigen-independent accumulation of activated effector/memory T lympho-
cytes into human and murine tumors. Int J Cancer 118: 1205–1214.
25. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, et al. (1995) Cloning
of a new cytokine that induces IFN-gamma production by T cells. Nature 378:
88–91.
26. Berg RE, Cordes CJ, Forman J (2002) Contribution of CD8+ T cells to innate
immunity: IFN-gamma secretion induced by IL-12 and IL-18. Eur J Immunol
32: 2807–2816.
27. Berg RE, Forman J (2006) The role of CD8 T cells in innate immunity and in
antigen non-specific protection. Curr Opin Immunol 18: 338–343.
28. Denton AE, Doherty PC, Turner SJ, LaGruta NL (2007) IL-18, but not IL-12, is
required for optimal cytokine production by influenza virus-specific CD8+ T
cells. Eur J Immunol 37: 368–375.
29. vonGeldern M, Simm B, Braun M, Weiss EH, Schendel DJ, et al. (2006) TCR-
independent cytokine stimulation induces non-MHC restricted T cell activity
and is negatively regulated by HLA class I. Eur J Immunol 36: 2347–2358.
30. Lertmemongkolchai G, Cai G, Hunter CA, Bancroft GJ (2001) Bystander
activation of CD8+ T cells contributes to the rapid production of IFN-gamma in
response to bacterial pathogens. J Immunol 166: 1097–1105.
31. Nitcheu J, Bonduelle O, Combadiere C, Tefit M, Seilhean D, et al. (2003)
Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate
experimental cerebral malaria pathogenesis. J Immunol 170: 2221–2228.
32. Nathanson JA, Chun LL (1989) Immunological function of the blood-
cerebrospinal fluid barrier. Proc Natl Acad Sci USA 86: 1684–1688.
33. Marelli-Berg FM, Scott D, Bartok I, Peek E, Dyson J, et al. (2001) Antigen
presentation by murine endothelial cells. Transplant Proc 33: 315–316.
34. Weis N, Lindhardt BO, Kronborg G, Hansen AB, Laursen AL, et al. (2006)
Impact of hepatitis C virus coinfection on response to highly active antiretroviral
therapy and outcome in HIV-infected individuals: a nationwide cohort study.
Clin Infect Dis 42: 1481–1487.
35. Rall GF (2003) Measles virus 1998-2002: progress and controversy. Ann Rev
Micro 57: 343–367.
36. Rochford R, Cannon MJ, Moormann AM (2005) Endemic Burkitt’s lymphoma:
a polymicrobial disease? Nat Rev Micro 3: 182–187.
37. Gran B, Rostami A (2001) T cells, cytokines, and autoantigens in multiple
sclerosis. Curr Neurol Neurosci Rep 1: 263–270.
38. Huang YH, Zozulya AL, Weidenfeller C, Metz I, Buck D, et al. (2009) Specific
central nervous system recruitment of HLA-G+ regulatory T cells in multiple
sclerosis. Ann Neurol 66: 171–183.
39. Moisse K, Strong MJ (2006) Innate immunity in amyotrophic lateral sclerosis.
Biochim Biophys Acta 1762: 1083–1093.
40. Papadimitriou D, LaVerche V, Jacquier A, Ikiz B, Przedborski S, et al. (2010)
Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiol
Dis 37: 493–502.
41. Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, et al. (2010)
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple
sclerosis. Neurology 74: 1127–1135.
42. Martin C, Enbom M, Soderstrom M, Fredrikson S, Dahl H, et al. (1997)
Absence of seven human herpesviruses, including HHV-6, by PCR in CSF and
blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand
95: 280–283.
43. Kim YJ, Fan Y, Laurie P, Kim JM, Ravits J (2009) No evidence of HIV pol gene
in spinal cord tissue on sporadic ALS by real time RT-PCR. Amyotroph Lateral
Scler 11: 91–96.
44. Walker MP, Schlaberg R, Hays AP, Bowser R, Lipkin WI (2001) Absence of
echovirus sequences in brain and spinal cord of amyotrophic lateral sclerosis
patients. Ann Neurol 49: 249–253.
45. Consilvio C, Vincent AM, Feldman EL (2004) Neuroinflammation, COX-2,
and ALS - a dual role? Exper Neurol 187: 1–10.
46. Grigoriadis N, Grigoriadis S, Polyzoidou E, Milonas I, Karussis D (2006)
Neuroinflammation in multiple sclerosis: evidence for autoimmune dysregula-
tion, not simple autimmune reaction. Clin Neurol Neurosurg 108: 241–244.
47. Streit WJ, Mrak RE, Griffin WST (2004) Microglia and neuroinflammation: a
pathological perspective. J Neuroinflammation 1: 1–14.
48. Gilden DH (2005) Infectious causes of multiple sclerosis. Lancet Neurol 4:
195–202.
CNS Immunopathology following Viral Co-infection
PLoS Pathogens | www.plospathogens.org 13 December 2011 | Volume 7 | Issue 12 | e1002462
